Cargando…
Shared GABA transmission pathology in dopamine agonist- and antagonist-induced dyskinesia
Dyskinesia is involuntary movement caused by long-term medication with dopamine-related agents: the dopamine agonist 3,4-dihydroxy-L-phenylalanine (L-DOPA) to treat Parkinson’s disease (L-DOPA-induced dyskinesia [LID]) or dopamine antagonists to treat schizophrenia (tardive dyskinesia [TD]). However...
Autores principales: | Abe, Yoshifumi, Yagishita, Sho, Sano, Hiromi, Sugiura, Yuki, Dantsuji, Masanori, Suzuki, Toru, Mochizuki, Ayako, Yoshimaru, Daisuke, Hata, Junichi, Matsumoto, Mami, Taira, Shu, Takeuchi, Hiroyoshi, Okano, Hideyuki, Ohno, Nobuhiko, Suematsu, Makoto, Inoue, Tomio, Nambu, Atsushi, Watanabe, Masahiko, Tanaka, Kenji F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10591040/ https://www.ncbi.nlm.nih.gov/pubmed/37774703 http://dx.doi.org/10.1016/j.xcrm.2023.101208 |
Ejemplares similares
-
Behavioral effects of zonisamide on L-DOPA-induced dyskinesia in Parkinson's disease model mice
por: Sano, Hiromi, et al.
Publicado: (2023) -
The hnRNP C tetramer binds to CBC on mRNA and impedes PHAX recruitment for the classification of RNA polymerase II transcripts
por: Dantsuji, Sayaka, et al.
Publicado: (2023) -
Pathophysiology, prognosis and treatment of tardive
dyskinesia
por: Takeuchi, Hiroyoshi, et al.
Publicado: (2022) -
Biliary Dyskinesia in Stiff Person Syndrome: An Association Between Reduced GABA Production and Gastroenteric Dysmotility
por: Louis-Jean, Scarlet, et al.
Publicado: (2023) -
Maladaptive Plasticity in Levodopa-Induced Dyskinesias and Tardive Dyskinesias: Old and New Insights on the Effects of Dopamine Receptor Pharmacology
por: Cerasa, Antonio, et al.
Publicado: (2014)